• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Analysis of the first-year cost of a prostate cancer screening and treatment program in the United States.

作者信息

Lubke W L, Optenberg S A, Thompson I M

机构信息

Department of Urology, Wilford Hall Medical Center, San Antonio, Tex.

出版信息

J Natl Cancer Inst. 1994 Dec 7;86(23):1790-2. doi: 10.1093/jnci/86.23.1790.

DOI:10.1093/jnci/86.23.1790
PMID:7966418
Abstract
摘要

相似文献

1
Analysis of the first-year cost of a prostate cancer screening and treatment program in the United States.美国前列腺癌筛查与治疗项目首年成本分析。
J Natl Cancer Inst. 1994 Dec 7;86(23):1790-2. doi: 10.1093/jnci/86.23.1790.
2
Benefit and cost of prostate cancer early detection.前列腺癌早期检测的益处与成本。
CA Cancer J Clin. 1993 May-Jun;43(3):133. doi: 10.3322/canjclin.43.3.133.
3
Prostate cancer: new hope, new controversy.
Hosp Technol Ser. 1994 Aug;13(10):1-4.
4
An overview cost-utility analysis of prostate cancer screening.前列腺癌筛查的成本效用分析概述
Oncology (Williston Park). 1995 Nov;9(11 Suppl):141-5.
5
Economic evaluation of a prostate cancer screening program in France: a decision model.法国前列腺癌筛查项目的经济评估：一个决策模型。
Crit Rev Oncol Hematol. 1999 Nov;32(2):167-73. doi: 10.1016/s1040-8428(99)00033-5.
6
Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.基于前列腺特异性抗原（PSA）的前列腺癌人群筛查：一项经济学分析。
Ont Health Technol Assess Ser. 2015 May 1;15(11):1-37. eCollection 2015.
7
[Evaluation of mass screening for prostatic cancer].[前列腺癌群体筛查的评估]
Nihon Rinsho. 2002 Dec;60 Suppl 11:289-93.
8
[Knowledge about effectiveness of general screening for prostatic cancer is limited].关于前列腺癌一般筛查有效性的知识有限。
Lakartidningen. 1992 Nov 4;89(45):3835-8.
9
Lack of expertise and funding are hampering prostate cancer screening and treatment.专业知识和资金的匮乏阻碍了前列腺癌的筛查和治疗。
BMJ. 2002 Dec 7;325(7376):1322. doi: 10.1136/bmj.325.7376.1322/e.
10
Finance issue brief: mandated benefits: prostate cancer screening coverage requirements: year end report-2003.
Issue Brief Health Policy Track Serv. 2003 Dec 31:1-5.

引用本文的文献

1
Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies.基于对已发表研究的系统评价对前列腺癌筛查、诊断及分期的成本分析
Prev Chronic Dis. 2007 Oct;4(4):A100. Epub 2007 Sep 15.
2
The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.加拿大前列腺癌的经济负担：蒙特利尔前列腺癌模型的预测
CMAJ. 2000 Apr 4;162(7):987-92.
3
The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.加拿大前列腺癌的临床负担：来自蒙特利尔前列腺癌模型的预测。
CMAJ. 2000 Apr 4;162(7):977-83.
4
Approaches to missing data inference results from CaPSURE: an observational study of patients with prostate cancer.
Pharmacoeconomics. 1999 Feb;15(2):197-204. doi: 10.2165/00019053-199915020-00007.
5
Prostate cancer screening (United States).
Cancer Causes Control. 1995 May;6(3):267-74. doi: 10.1007/BF00051798.